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Abstract
The Sonoda–Tajima Cell Collection includes cell samples obtained from a range of ethnic minority groups across the world
but in particular from South America. The collection is made all the more valuable by the fact that some of these ethnic
populations have since died out, and thus it will be impossible to prepare a similar cell collection again. The collection was
donated to our institute, a public cell bank in Japan, by Drs Sonoda and Tajima to make it available to researchers throughout
the world. The original cell collection was composed of cryopreserved peripheral blood samples that would obviously
have been rapidly exhausted if used directly. We, therefore, immortalized some samples with the Epstein–Barr virus and
established B-lymphoblastoid cell lines (B-LCLs). As there is continuing controversy over whether the B-LCL genome is stably
maintained, we performed an array comparative genomic hybridization (CGH) analysis to conﬁrm the genomic stability of
the cell lines. The array CGH analysis of the B-LCL lines and their parental B cells demonstrated that genomic stability
was maintained in the long-term cell cultures. The B-LCLs of the Sonoda–Tajima Collection will therefore be made available
to interested scientists around the world. At present, 512 B-LCLs have been developed, and we are willing to increase the
number if there is sufﬁcient demand.
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Introduction
Human T-lymphotropic virus type 1 (HTLV-I) is the causative
virus of adult T-cell leukemia (Uchiyama et al. 1977)a n d
HTLV-I–associated chronic myelopathy (Osame et al. 1986).
HTLV-I is distributed worldwide and is phylogenetically clas-
siﬁed into three major subtypes: the Central African group
detected in the Central African continent; the Melanesian
group located around Australia; and the Cosmopolitan
(Mongoloid) group widely spread across the Asian region
of the Eurasian continent (reviewed by Yamashita et al.
1996 and by Sonoda et al. 2011). HTLV-II, which is closely
related to HTLV-I but is a distinct virus, is also classiﬁed
into two major groups, HTLV-IIa and HTLV-IIb. HTLV-II is also
detected worldwide and its distribution shows some geo-
graphic bias, that is, HTLV-IIa0 and a3 were predominantly
detected in nonindigenous populations in North America;
a4 and b1 were speciﬁcally detected in indigenous people
in North and South America, respectively; b5 was mainly de-
tected in indigenous populations in both North and South
America; Only a2 and b4 were detected within European
populations (Switzer et al. 1995).
To conﬁrm the reported patterns of geographic and
ethnic segregation of human HTLV-I and -II in human pop-
ulations, Sonoda, Tajima and colleagues conducted seroepi-
demiological studies of indigenous populations in South
America who lived in closed societies (Komurian-Pradel
et al. 1992; Ijichi et al. 1993; Miura et al. 1994, 1997;
Fujiyoshi et al. 1999; Li et al. 1999). In this series of analyses
that included both extant populations and the preserved
remains of prehistoric mummies, they showed that the
Amerind populations retained the Mongoloid subtype of
HTLV-I (Miura et al. 1994, 1997; Li et al. 1999; reviewed
by Sonoda et al. 2011) and a distinctive subclass of HTLV-
IIb (Ijichi et al. 1993; Miura et al. 1997). They also showed
that there was a geographic bias in the distribution of HTLV-
I/-II carriers: HTLV-I predominated in the Andes Highlands,
whereas there were foci of HTLV-II in the lowlands of South
America. From these results, they concluded that ancestors
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GBEof the Amerind populations carried HTLV-I and -II into the
South American continent from the Eurasian continent over
10,000 years ago and that the indigenous South American
populations could be divided into two major ethnic groups.
During the course of these studies, a number of periph-
eral blood samples were obtained and cryopreserved with
the consent of the donors, not only for immediate use
but also for future studies. In addition to these samples,
many other peripheral blood samples were collected from
isolated ethnic populations in various areas around the
world (ﬁg. 1). All these samples have been donated to
a not-for-proﬁt public cell bank held at the Cell Engineering
Division of RIKEN BioResource Center in Tsukuba, Japan.
Overall, more than 3,500 blood samples were donated to
the cell bank.
One obvious problem with these cryopreserved periph-
eral blood samples is that if they are used for experimental
studies, then they would quickly run out. Because these
samples are an extremely precious resource for future re-
search in human genetics, it was decided that they should
be preserved in a form that could be expanded repeatedly.
One well-established method is to transform B-lymphoid
cells in peripheral blood using the Epstein–Barr virus (EBV)
(Nilsson 1979). The genomic stability of B-lymphoblastoid
cell lines (B-LCLs) transformed by EBV has been evaluated,
such as by karyotyping using conventional G-band staining
(reviewed by Nilsson 1992; Okubo et al. 2001) and by anal-
ysisofparticulargeneticlociformutations(Lalleetal.1995).
Those analyses indicate that the genome of these B-LCLs is
stable. Recent technical advances have now opened up the
possibility of a more stringent evaluation of genomic sta-
bility in B-LCLs. For example, Simon-Sanchez et al. (2006)
and Herbeck et al. (2009) compared genome-wide single-
nucleotide polymorphism (SNP) patterns in B-LCLs and
parental B cells (i.e., the original cells that B-LCLs were de-
rived from) and concluded that there were no statistically
signiﬁcant differences between the cell types. By contrast,
the Wellcome Trust Case Control Consortium analyzed copy
number variation (CNV) over 3,400 loci and detected dif-
ferences between B-LCLs and their parental cells at a sig-
niﬁcant number of loci (The Wellcome Trust Case Control
Consortium 2010).
To analyze the genomic stability of B-LCLs, we performed
array comparative genomic hybridization (CGH) analysis
using 11 B-LCLs and their parental cells. This analysis con-
ﬁrmed the stability of the genomes of the B-LCLs. We have,
therefore, now established more than 500 B-LCLs from the
cryopreserved cellsamples oftheSonoda–TajimaCollection.
FIG.1 . —Hypothetical pathways of prehistoric human migration. Red arrows indicate hypothetical prehistoric migration routes of humans after
leaving Africa approximately 70 thousand years ago. The numbers in boxes indicate the number of individuals who donated blood samples. The yellow
circles indicate the approximate geographic locations where the blood samples were collected.
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include as many ethnic populations from South America as
possible.
Materials and Methods
Peripheral Blood Samples
Theethnicpopulationswhokindlydonatedperipheralblood
samples following informed consent and the numbers of
individuals involved are given in table 1. The approximate
geographic locations where the samples were collected
are shown in ﬁgure 2. Peripheral blood mononuclear cells
(PBMNCs) were separated from each blood sample and cry-
opreserved in liquid nitrogen until use in this study. The eth-
ical committee of the RIKEN Tsukuba Institute approved the
use of these samples before the study was initiated.
Establishment of B-LCLs
B-LCLs were established using previously reported methods
(Bird et al. 1981; Rickinson et al. 1984). The B95-8 cell line
was obtained from the Cell Resource Center for Biomedical
Research, TohokuUniversity (Sendai,Miyagi, Japan)andcul-
tured in RPMI 1640 (Gibco) supplemented with 10% fetal
bovine serum (FBS). The culture supernatant of the B95-8
cells was collected, ﬁltered to remove cells, cryopreserved,
and used as the source of EBV. For infection of PBMNCs
with EBV, the B95-8 culture supernatant was thawed
and incubated with the PBMNCs at 37  C for 2 h. The cells
were then washed with RPMI, resuspended in RPMI1640
supplemented with 20% FBS and 0.5 lg/ml cyclosporin A
(Sandimmun; Novartis Pharma), inoculated into a multiwell
plate at a cell density of approximately 2   10
5 cells/cm
2,
andcultured.Halfofthemediumwaschangedtwiceaweek
with replacement by fresh medium. After a few weeks and
upon conﬁrming efﬁcient proliferation of the cells, the cul-
tureswerescaledupusinga2-to4-folddilutioninto75-cm
2
culture ﬂasks. B-LCLs around passage 10 were deposited
in the cell bank of the Cell Engineering Division of RIKEN
BioResource Center (RIKEN Cell Bank) and were used for
the following analyses.
Microsatellite Polymorphism Analysis
To authenticate the identity of each cell line, short tandem
repeat (STR) polymorphisms in microsatellites wereanalyzed
in genomic DNA using the PowerPlex1.2 kit (Promega). This
PCR-based analysis kit includes the primer sets required to
detect STR polymorphisms at eight loci (Masters et al. 2001;
Yoshino et al. 2006).
Karyotype Analysis
Chromosome preparations were madein a standardfashion
and then G-banded (Yunis et al. 1978). Chromosome num-
bers were counted in 50 cells (mode analysis), and then the
G-band pattern was analyzed in detail in 20 of the cells to
identifychromosomeaberrations(karyotypeanalysis).These
analyses were performed for us by Nihon Gene Research
Laboratories (Sendai, Miyagi, Japan).
Collection of B-Lineage Cells from Blood Samples
The anti-FITC (ﬂuorescein isothiocyanate) MultiSort Kit (Mil-
tenyi Biotech) and an MACS MS column (Miltenyi Biotec)
were used to collect CD19-positive (CD19
þ) B-lineage cells
from PBMNCs and umbilical cord blood mononuclear cells
according to the manufacturer’s instructions with slight
modiﬁcation. Brieﬂy, to remove any dead cells, approxi-
mately 5   10
7 cells were passed through the column with-
out staining with antibodies. Phosphate-buffered saline
supplemented with 0.5% FBS and 0.05% sodium azide
was used to wash the column. The collected viable cells
were stained with FITC-labeled anti-human CD19 antibody
(BD Biosciences) and then reacted with anti-FITC MultiSort
beads. We collected CD19
þ B-lineage cells attached to
MultiSort beads. After removal of the beads by proteolytic
cleavage, genomic DNA was extracted from the cells. Cell
numbers at each step were counted with a hematocytome-
ter, and the purity of the CD19
þ cells was analyzed with an
FACS Calibur ﬂow cytometer (BD Biosciences). On average,
approximately 5   10
5 CD19
þ cells were collected from 5  
10
7 PBMNCs.
Array CGH Analysis
Genomic DNA was obtained from the cells using a DNeasy
Blood and Tissue Kit (Qiagen). Preparation of the ﬂuores-
cent-labeled samples for array CGH analysis was performed
according to the manufacturer’s instructions. Brieﬂy, 1.0–
1.5 lg of genomic DNA was digested with the restriction
endonucleases AluI and RsaI. Then, genomic DNAs from
PBMNCs and CD19-negative (CD19
 ) cells were labeled
with cyanine 3-dUTP (Cy3) and genomic DNAs from B-LCLs
and CD19
þ cells were labeled with cyanine 5-dUTP (Cy5)
using a Genomic DNA Enzymatic Labeling Kit (Agilent).
After evaluating labeling efﬁciency, Cy3-labeled and Cy5-
labeled DNAs were mixed in the Oligo aCGH/ChIP-on-chip
HybridizationKit(Agilent)andthenhybridizedonaSurePrint
G3 Human CGH 2   400 K microarray (Agilent) at 65  C for
40 h in a hybridization oven, with rotation at 20 rpm. The
microarrays were scanned with a DNA Microarray Scanner
(Agilent) at 3-lm resolution. To quantify the intensity of the
ﬂuorescent signal of each spot on the microarray, we used
Feature Extraction software version 10.5.1.1 (Agilent).
Statistical Analysis
The array CGH analysis data were evaluated to identify
genomic alterations by a statistical analysis with Genomic
Workbench Standard Edition version 5.0.14 (Agilent). The
conditions and parameters of the statistical analysis were
Danjoh et al. GBE
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ear at a 2-Mb window size, the ADM-2 algorithm threshold
was set to 6.0 with Fuzzy Zero, the aberration ﬁlters were
applied at a minimum number of probes of 3 in the region
Table 1
Mongoloid Minority Populations Included in This Study
Country Location Tribe Other Name
Latitude
(degrees N)
Longitude
(degrees W)
B-LCL Established
M F Total
Venezuela 1 Sanema
(Sanuma ´)
Sanuma ´, Chirichano, Guaika,
Samatali, Samatari, Sanima,
Tsanuma, Xamatari
3.5 64.5 13 9 22
2 Ye’Kuana Maquiritari, Cunuana, De’cuana,
Maiongong, Maquiritai, Maquiritare,
Pawana, Soto, Ye’cuana
3.5 64.5 6 14 20
Colombia/
Venezuela
3 Piaroa Adole, Ature, Guagua,
Kuakua, Quaqua
5 6 7 224
Colombia 4 Amorua;
Guahibo
–– 6 67.5 0 2 2
5 Etnia Siquani;
Guahibo
–– 6 67.5 2 1 3
6 Siquani;
Guahibo
–– 6 67.5 4 1 5
7 Guahibo Goahibo, Goahiva, Guaigua,
Guajibo, Guayba, Sicuani,
Sikuani, Wahibo
6 67.5 3 2 5
8 Ticuna Tikuna, Tucuna, Tuku ´na 4 69.5 6 14 20
9 Wayu Wayuu, Guajiro, Goajiro, Guajira,
Ua ´ira, Waiu, Wayu ´u, Wayuunaiki
11.5 73 36 62 98
10 Wayuu
Epiayu
–– 11.5 73 0 2 2
11 Wayuu
Puchaina
–– 11.5 73 1 1 2
12 Wayuu
Uriana
–– 11.5 73 2 2 4
13 Matapi Yucuna, Yukuna  1 69.5 1 0 1
14 Miran ˜a Bora, Boro, Meamuyna  1 69.5 0 1 1
15 Cumbal –– 1 78 4 11 15
16 Inga Highland Inga 1 77 3 13 16
17 Kamsa Camsa ´, Came ¨ntse ¨a ´, Coche,
Kamemtxa, Kamse, Sibundoy
1 77 3 17 20
Ecuador 18 Can ˜ar Can ˜ar Highland Quichua  2.5 79 7 20 27
19 Saraguro Loja Quichua, Saraguro Quichua  3.5 79.5 7 15 22
Bolivia 20 Aymara ––  16 to  18.5 68.5–69 15 13 28
21 Chipaya Puquina  18.5 68.5 5 3 8
22 Quechua North La Paz Quechua  21.5 to  21 66–67.5 13 12 25
23 Mestizo ––  20 to  21 65.5–66 2 1 3
Paraguay 24 Chaco (Lengua) Enxet  22.5 59.5 18 17 35
25 Chaco (Nivacle ´) Ashlushlay, Axluslay,
Chulupe, Chulupı ´,
Chulupie, Churupı ´, Nivakle ´
22.5 59.5 9 2 11
26 Chaco (Sanapana ´) Lanapsua, Quiativis,
Quilyacmoc, Saapa, Sanam
 22.5 59.5 1 0 1
Chile 27 Atacama Kunza, Atacamen ˜o,
Likanantaı ´, Lipe, Ulipe
 23 to  23.5 68 14 13 27
28 Mapuche Mapudungun, Araucano,
Mapudungu
 39 71.5–72 26 33 59
29 Huilliche Huiliche, Veliche  43 73 5 4 9
Argentina 30 Puna ––  22.5 65.5 7 17 24
Total 215 304 519
NOTE.––Other names were referred to by Ethnologue country index (http://www.ethnologue.com/country_index.asp); ‘––’ indicates not entried in Linguist group.
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After the ﬁrst screening described above, the raw data of se-
lected loci were individually scrutinized. As a result, some
‘‘aberrations’’ were removed from the aberration list because
they were located within a noisy area, such at the telomeres,
and the reliability of the aberration calls in such region was
low. Although GenomicWorkbenchStandard Edition version
5.0.14 adopts hg18 for gene mapping, we referred to Build
36.3 in the Map Viewer constructed by National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/
projects/mapview/) for detailed mapping of genes.
V(D)J Recombination Analysis
Recombination in the V(D)J region of the immunoglobulin
(Ig) heavy-chain gene in B-LCLs was analyzed by PCR as
described previously with slight modiﬁcation (Kiyoi et al.
1992; Abe et al. 1994). The primers used for the PCR
were 5#-GAG TCG AC(A/T) C(A/G)G C(G/CXG/A)T GTA
(T/C)T(T/A) CTG-3# for the V common region and 5#-CCA
AGC TTA CCT GAG GAG ACG GTG A-3# for the J common
region. PCR was performed using an ExTaq polymerase kit
(TaKaRa Bio) with a reaction mixture containing 0.4 lMo f
the J common primer and 4 lM of the V common primer.
An initial incubation at 94  C for 5 min was followed by 40
cycles of denaturation at 94  C for 10 s, annealing at 60  C
for 1 s, extension at 72  C for 15 s, and ﬁnally incubation
at 72  C for 5 min. The PCR products were separated on
3% NuSieve GTG agarose gels (Lonza) and visualized by
ethidium bromide staining. Expected product sizes from
recombined V(D)J region were in the range 50–200 bp.
Results
The Sonoda–Tajima Cell Collection
The Sonoda–Tajima Cell Collection contains more than
3,500 PBMNC samples obtained from ethnic populations
across the world (ﬁg. 1). The collection is particularly rich
in samples from South America. As stated earlier, any direct
use of the PBMNC samples would soon lead to their exhaus-
tion. In comparison with the in vitro expansion of the whole
genome using PCR, establishing cell lines is a much better
method for maintaining the whole genome in a stable man-
ner. With regard to establishing cell lines from PBMNCs,
the generation of B cell lines using EBV (B-LCLs) is the most
common approach. The genomic DNA of B-LCLs is main-
tained in a stable fashion. These facts encouraged us to
establish B-LCLs using the PBMNCs of the Sonoda–Tajima
Cell Collection. In order to include as many ethnic groups
as possible from South America and a sufﬁcient number
of individuals in each group, we selected the samples indi-
cated in table 1 and ﬁgure 2.
When we used either fresh or cryopreserved PBMNCs in
good condition to establish the B-LCLs, we were successful
in all cases. However, the PBMNC samples in the Sonoda–
Tajima Cell Collection have been cryopreserved for over 20
years. In addition, in sampling areas where no electricity was
available, the samples were kept at relatively high temper-
atures prior to cryopreservation. As a consequence of these
factors, the viability of some of the thawed PBMNC samples
was low, that is, the cells were in poor condition after thaw-
ing, and thus it was not easy to establish B-LCLs for these
samples. Overall, a success rate of approximately 80% was
achieved for the establishment of B-LCLs from the PBMNC
samples of the Sonoda–Tajima Cell Collection. Because the
success rate was less than 100%, we decided not to use
samples for which there were only one or two tubes cryo-
preserved. Future treatment of such samples remains to
be considered. At the moment, we have established 512
B-LCLs from the Sonoda–Tajima Cell Collection. Information
on the established B-LCLs is given in table 1 and ﬁgure 2.
Karyotype Analysis
In contrast to other cell lines, such as immortalized cancer
cell lines, one of the most signiﬁcant features of B-LCLs is
FIG.2 . —Geographic locations where blood samples were col-
lected. Red circles indicate the approximate locations where the blood
samples were collected. The numbers in circles correspond to the
location numbers in table 1.
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mosome karyotype even after relatively long-term culture
(reviewed by Nilsson 1992; Lalle et al. 1995; Okubo et al.
2001); thus, they have been widely used for genetic analysis
FIG.3 . —Karyotype analysis. The karyotypes of the three cell lines YAN3268 (A), WY084 (B), and YAN3191 (C) were analyzed. A representative
karyotype of the sample of 20 cells karyotyped and 50 mode-analyzed cells. The chromosome notation system follows the guidelines in ISCN (An
International System for Human Cytogenetic Nomenclature) 1991.
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lished from the Sonoda–Tajima Cell Collection maintained
a normal karyotype, three B-LCL cell lines, WY084,
YAN3191 and YAN3268, were karyotyped following G-
banding of chromosome preparations. Chromosome num-
bers were counted in 50 cells (mode analysis), and then
a detailed G-band analysis was performed in 20 of these
cells to identify chromosome aberrations. Consistent with
previous reports, the vast majority of the cells had a normal
karyotype (ﬁg. 3). In the YAN3268 cell line, all the cells
analyzed had a normal chromosome number as well as a
normal karyotype (ﬁg. 3A). In the WY084 cell line, 2 of
the 50 cells had a reduced chromosome number (ﬁg. 3B).
This might have been an artifact of preparation as no struc-
tural aberrations were observed in the cells. In the YAN3191
cell line, all 20 karyotyped cells had an elongated pericen-
tromeric region on the long arm of chromosome 1 (ﬁg. 3C).
The centric heterochromatin of chromosome 1 is known to
be variable and shows heteromorphism between individuals
(http://www.rerf.or.jp/dept/genetics/giemsa_5_e.html).
Ingeneral,ifanirregularkaryotypeisdetected,itisnotpos-
sible to conclude that it arose during culture because there is
a possibilityitwasalready present inthe cells oftheindividual
fromwhomtheinitialsamplewasobtained,asintheYAN3191
cell line. In addition, because karyotype analysis has a limited
resolution (3–5 Mbp), we cannot detect smaller rearrange-
ments. These limitations prompted us to perform the array
CGH analysis on the B-LCLs and their parental PBMNCs.
Array CGH Analysis
To avoid the inﬂuence of genetic background, such as CNV,
we decided to compare the B-LCL and parental PBMNC
from the same person in our experiments. We analyzed
10 B-LCLs derived from the Sonoda–Tajima Cell Collection
and one B-LCL derived from a healthy Japanese volunteer.
Theprobesetusedinthemicroarraywasuninformativere-
gardingtheheterochromaticregionofchromosome1.How-
ever,in theYAN3191cellline,wedidnotdetectanyvariants
with respect to the other chromosome 1 probes suggesting
that there was no major rearrangement of the chromosome
(oroftheotherchromosomes)andthatthecelllineessentially
retained the innate genomic structure (ﬁg. 4).
A few aberrations were observed in all 11 samples: a de-
letion in chromosome 14 (in the variable, diversity or joining
regions of the Ig heavy chain); a deletion in chromosome 2
(in the variable or joining regions of the Ig j light chain);
an ampliﬁcation in chromosome 14 (in the variable or join-
ing regions of the T-cell receptor [TCR]-a chain); and an
ampliﬁcation in chromosome 7 (in the variable, joining or
constant regions of the TCR-c chain). Typical examples of
chromosome 14 are shown in ﬁgure 5. In addition, a few
other aberrations were detected in some but not all cell
lines: a deletion at the immunoglobulin k locus on chromo-
some 22; and ampliﬁcation at the TCR-b on chromosome 7.
A precise description of each aberration locus and aberra-
tion type described above is given in table 2 and ﬁgure 6.
In addition, a few other speciﬁc aberrations were observed
in some but not all B-LCLs (supplementary ﬁgs. S1–S4,
Supplementary Material online).
In the B-LCLs, it is possible that the deletions detected
in the regions associated with the Ig genes were already
presentintheBlymphocytespriortoEBVinfection.Similarly,
because the population of B-lineage cells in PBMNCs is
very small, it is possible that the detected aberrations were
already present in the parent B lymphocytes but not in the
non-B cells. To examine this latter possibility, we attempted
to compare the genomes of B-lineage and non–B-lineage
cells. However, it was impossible to obtain sufﬁcient B-
lineage cells from the Sonoda–Tajima Collection. Thus,
we used a blood sample from one healthy Japanese adult
volunteer and two umbilical cord blood samples obtained
from two independent Japanese neonates. CD19
þ and
CD19
  cell populations were collected using the magnetic
beads system described earlier (see Materials and Methods).
After selection, the proportion of CD19
þ cells was approx-
imately 90% (ﬁg. 7B and C).
Asexpected,mostaberrationsobservedinB-LCLcelllines
were also observed in all CD19
þ cells: deletions at the Ig
heavy chain on chromosome 14 and at the Ig j and k light
chainsonchromosomes2and22;ampliﬁcationsattheTCR-
a locus on chromosome 14, and at the TCR-b and c-loci on
chromosome 7. A precise description of each aberration
locus and aberration type is also described in table 2 and
ﬁgure 6.
FIG.4 . —Array CGH of chromosome 1 of the YAN3191 cell line. The acquired hybridization signal for chromosome 1 is shown. Dots indicate
probes arrayed on the microarray. Red, green and black signals indicate probes that were called ‘‘ampliﬁed,’’ ‘‘decreased,’’ or ‘‘no change,’’ respectively,
at the corresponding genomic regions in the YAN3191 cell line compared with PBMNCs.
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278 Genome Biol. Evol. 3:272–283. doi:10.1093/gbe/evr014 Advance Access publication March 7, 2011FIG.5 . —An example of array CGH analysis showing the results for chromosome 14. (A) The acquired hybridization signal for the entire
chromosome 14. (B, C) Expanded images around 14q11.2 (B) and 14q32.33 (C). The dots in (A) and the crosses in (B) and (C) indicate probes arrayed on
the microarray. The red, green and black signals indicate probes that were called ‘‘ampliﬁed,’’ ‘‘decreased,’’ or ‘‘no change,’’ respectively, in B-LCLs
compared with PBMNCs in YAN3268, YAN3191, and YAN3143 and in CD19
þ cells compared with CD19
  cells in Cord Blood-1, Cord Blood-2, and the
Adult Japanese sample.
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major cell population in the PBMNCs was CD3
þ T-lineage
cells (ﬁg. 7A), the results of the statistical analysis of array
CGH suggested that ‘‘ampliﬁcation’’ at the TCR loci were
highly likely due to deletions at these loci in T-lineage cells
rather than ampliﬁcation in B-lineage cells.
V(D)J Recombination Analysis
The array CGH analysis clearly demonstrated that B-LCLs
possessed rearranged Ig genes. To conﬁrm the rearrange-
ment of the Ig heavy chain, we performed a PCR analysis
on genomic DNAs from the B-LCLs. The variable region
of the Ig heavy chain is encoded by 3 gene clusters: approx-
imately 40 functional variable (V) genes, 6 functional join-
ing (J) genes, and 25 functional diversity (D) genes. At
the later stages of B-lymphocyte differentiation, this region
undergoes genomic rearrangements such that only one
randomlyselectedgenefromeachgeneclusterisconnected
to form the mature V(D)J variable gene, and the remaining
‘‘left over’’ genes are removed from the genome (summa-
rized in OMIM #147070, http://www.ncbi.nlm.nih.gov/
omim/). The PCR analysis identiﬁed V(D)J recombination
Table 2
Genomic Loci Where Aberrations Were Detected
Chromosome Cytoband Start Stop Pattern Gene Name
Detected in
all samples
2 p11.2 88916534 89743016 Deletion Immunoglobulin kappa
J, V clusters
7 p14.1 38262501 38349233 Ampliﬁcation TCR-gamma C, J, V clusters
14 q11.2 21485151 22050050 Ampliﬁcation TCR-alpha V, J clusters
14 q32.33 105314054 106286079 Deletion Immunoglobulin heavy chain
V, D, J clusters
Detected in
over ﬁve samples
7 q34 141988254 142202474 Ampliﬁcation TCR-beta V, J clusters
16
ab q22.1 66945730 66967713 Ampliﬁcation/deletion LOC100129324, sphingomyelin
phosphodiesterase 3
22 q11.22 20717615 21576029 Deletion Immunoglobulin lambda
V, J clusters
Detected in
2–4 samples
2
a q35 218971508 218979039 Ampliﬁcation MIRN26B, CTDSP1
3 p21.31 48577843 48600744 Ampliﬁcation UCN2, COL7A1
Detected only in
Dann and PBMNC
5 q35.3 179147890 179177396 Ampliﬁcation LTC4S, MGAT4B
a Aberration was not detected in B-lymphocyte population.
b Aberration was not detected in B-LCL established from adult Japanese.
FIG.6 . —Panel of aberration loci in each cell. Red and green columns indicate the loci called as ampliﬁcations and deletions, respectively. Yellow
columns indicate that the aberrations were detected under less stringent statistical conditions. Gray columns indicate no statistical differences.
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ysis and the PCR analysis were consistent with a previous
report that many B-LCLs secrete Ig into the culture medium
(Rosen et al. 1977). Because six of the lines showed a single
PCR product, these lines were each presumed to consist of
a single B-cell clone. However, the other cell lines showed
two or more PCR products indicating that they consisted
of two or more B-cell clones.
Discussion
Long-term cell culture lines, such as immortalized cancer
cell lines, generally possess abnormal karyotypes. However,
some cell lines tend to retain a normal karyotype. It is well
known that B-LCLs and pluripotent stem cell lines, such as
embryonic stem cells and induced pluripotent stem cells,
show this behavior. Due to this characteristic, B-LCLs have
been used in many projects, such as the International
Histocompatibility Working Group (http://www.ihwg.org/
cellbank/cell_lines/blcl.html), International HapMap Project
(http://hapmap.ncbi.nlm.nih.gov/), and Human Genome
Diversity Project (http://www.cephb.fr/en/hgdp/table.php).
High throughput and comprehensive genome analyses have
recently been reported using B-LCL collections, for example,
FIG.7 . —FACS analysis to check the content of CD19
þ cells. (A) FACS analysis of PBMNCs stained with anti-CD3 and anti-CD19 antibodies. (B, C)
FACS analysis of CD19
þ-depleted cell population (B) and CD19
þ cell population (C) stained with anti-CD19 antibody after MACS beads separation,
respectively. Lower column indicates statistical analysis for each region shown in ﬁgures.
FIG.8 . —V(D)J recombination. PCR products were separated on
a gel and the ampliﬁed V(D)J recombination products are shown.
Fibroblasts were used as a recombination-negative control. PBMNCs and
CD19
þ cells (B-lineage cells) were used as multiclonal recombination-
positive controls. If the cell line is monoclonal, then a single band is
generated by PCR.
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tection of CNV (Redon et al. 2006), and population genetics
(Li et al. 2008).
It may be inevitable, however, that long-term cell cultures
will accumulate chromosomal aberrations and/or genetic
mutations. Additionally, it should be noted that there is
still some controversy over whether B-LCLs are truly immor-
talized cells. Sugimoto et al. (2004) reported that B-LCLs
could no longerproliferate following long-termculture,that
is, they showed the so-called ‘‘crisis’’ observed in human pri-
mary cell cultures. By chance, some B-LCLs can overcome
this crisis phase and continue to grow indeﬁnitely in culture,
that is, show immortalization; however, such cells also
showed malignant transformation with abnormal karyo-
types (Sugimoto et al. 2004). These ﬁndings have prompted
a vigorous debate on whether the genomes of B-LCLs are
really stable.
To address thisquestion, genome-wideevaluations ofthe
genomic stability of B-LCLs have recently been initiated.
Whole genome SNP genotyping indicated that the discrep-
ancies between B-LCLs and their parental PBMNCs were not
statistically signiﬁcant (Simon-Sanchez et al. 2006; Herbeck
et al. 2009). In contrast, however, another study has re-
ported different copy numbers of certain genes in B-LCLs
and their parental PBMNCs (The Wellcome Trust Case
Control Consortium 2010). In relation to this issue, Bruder
etal.(2008)analyzedCNVsinmonozygotictwinsandfound
somatic mosaicism for CNVs, that is, CNVs were detected
not only between individuals but also within an individual,
with a rate of 70–80% of blood cells affected in the most
severecasesandof10–15%inthe lessaffected cases.CNVs
form continuously in mitosis and meiosis by a diversity of
mechanisms, and it is thought that CNVs are one of the
major driving forces in the rapid evolution of human beings
(reviewed by Hastings et al. 2009).
In our array CGH analysis, several aberrations were
detected in B-LCLs when they were compared with
PBMNCs. However, most of these aberrations were also
detected in B-lineage cells when compared with non–B-
lineage cells. Therefore, it is highly likely that most of
theaberrationsdetectedintheB-LCLswerepresentintheir
parentalBcellsratherthanhavingoccurred denovoduring
establishment of the cell cultures. However, with respect
to some of the aberrations detected in some B-LCLs derived
from the Sonoda–Tajima Collection (supplementary ﬁgs.
S1–S4, Supplementary Material online), it was impossible
to determine whether they occurred de novo during culture
or were present in the parental B cells because insufﬁcient
numbers of parental B cells were available for analysis. Of
note, a deletion in chromosome 22 (in the variable and join-
ing regions of the Ig k light chain) was detected in several
B-LCLs but not in all lines, suggesting that EBV had infected
the B cells at different stages of differentiation, that is,
before and after the rearrangement of the Ig k light chain.
Interestingly, ampliﬁcation at 5q35.3 was only detected
in one of the two Japanese B-LCLs derived from the same
individual (ﬁg. 6). Of course, we cannot formally deny the
possibility of de novo ampliﬁcation during cell culture. How-
ever, this observation might indicate somatic mosaicism as
described above (Bruder et al. 2008). Even if this is the case,
it is not clear at present whether such somatic rearrange-
ments are coupled with RAG transposition (Reddy et al.
2010) or some other mechanism (reviewed by Hastings
et al. 2009). Moreover, with respect to aberrations of genes
other than of the Ig chains in B-LCLs and primary B cells,
the biological implications remain to be determined. When
B-LCLs are utilized in genetic research, such aberrations
need to be taken into account.
According to our array CGH results, the variation in copy
numbers of some genes in B-LCLs compared with their
parental PBMNCs might have been present in the parental
B cells and might have been detected if only B-lineage cells
had been collected and analyzed in a similar fashion to the
present study. The possible consequences of any CNV be-
tween B cells and non–B cells have yet to be investigated.
At present, we cannot formally exclude the possibility that
such CNV occurred during the establishment and culture
of the B-LCLs.
Overall, our analyses support the contention that B-LCLs
provide a valuable source of genomic DNAs for a wide ran-
ge of genetic studies. However, it is recommended that
short-term cell cultures are utilized. Certainly, so-called im-
mortalized B-LCLs with abnormal karyotypes (Okubo et al.
2001; Sugimoto et al. 2004) should not be used for genetic
research. In addition, the occurrence of aberrations in
B-LCLs when compared with whole mononuclear blood
cells should be taken into account when the affected
genomic loci are targeted for research.
The Sonoda–Tajima Cell Collection is a very valuable cell
collection obtained from various ethnic populations across
the world, particularly from South America. Because some
of these populations in South America no longer exist, it will
be impossible to prepare a similar collection in the future.
Here, we describe the establishment of B-LCLs from the
Sonoda–Tajima Cell Collection; currently, B-LCLs from more
than 500 of the total of about 3,500 samples have been
developed. All these B-LCLs are available from the cell bank
held at the Cell Engineering Division of RIKEN BioResource
Center in Japan (http://www.brc.riken.jp/lab/cell/english/).
At the moment, approximately 150 B-LCLs are immediately
available, whereas the others are now under preparation for
rapid distribution. In addition, we are willing to establish
more B-LCLs on demand from scientists around the world.
We believe that our development of this resource will
contribute to various ﬁelds of science such as human genet-
ics, human evolution, the history of human migrations
across continents, the pharmacokinetics of ethnic minority
groups, among others.
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